Gadoversetamide Injection Articles
FDA call for warning on contrast agents
4 June 2007
Mallinckrodt's OptiMARK completes Ph II trials
14 March 2005
Mallinckrodt Files For MRI Agent In USA
17 March 1998
Showing 1-3 of 3 articles
- 1
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
